Javier Arenas-Montes

Dr. Javier Arenas-Montes

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Animals
Verified
Journal Article
Open access
PDF file
JAJavier Arenas-Montes
Javier Arenas-Montes
PPPABLO PEREZ-MARTINEZ
PABLO PEREZ-MARTINEZ
CVCristina Vals-Delgado
Cristina Vals-Delgado
JRJuan Luis Romero-Cabrera
Juan Luis Romero-Cabrera
MPM Magdalena Perez-Cardelo
M Magdalena Perez-Cardelo
CMCarmen Marin
Carmen Marin
Pet ownership positively influences clinical outcomes in cardiovascular prevention. Additionally, cardiovascular disease (CVD) has been previously linked to microbiota dysbiosis. We evaluated the influence of owning a pet and its relationship with the intestinal microbiota. We analyzed the gut microbiota from 162 coronary patients from the CORDIOPREV study (NCT00924937) according to whether they owned pets (n = 83) or not (n = 79). The pet-owner group was further divided according to whether they owned dogs only (n = 28) or not (n = 55). A 7-item pet-owners test score was used. Patients who owned pets had less risk of metabolic syndrome (MetS) (OR = 0.462) and obesity (OR = 0.519) and were younger (p < 0.001) than patients who did not own pets. Additionally, patients who owned dogs had less risk of MetS (OR = 0.378) and obesity (OR = 0.418) and were younger (p < 0.001) than patients who did not own pets. A preponderance of the genera Serratia and Coprococcus was found in the group of owners, while the genera Ruminococcus, an unknown genus of Enterobacteriaceae and Anaerotruncus were preponderant in the group of non-owners. In patients who owned dogs, Methanobrevibacter and two more genera, Coprococcus and Oscillospira, were more common. Our study suggests that the prevalence of MetS and obesity in CVD patients is lower in pet owners, and that pet ownership could be a protective factor against MetS through the shaping of the gut microbiota. Thus, owning a pet could be considered as a protective factor against cardiometabolic diseases.

13 March 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
EPEsther Porras‐Pérez
Esther Porras‐Pérez
JRJuan Luis Romero-Cabrera
Juan Luis Romero-Cabrera
ACAlberto Díaz Cáceres
Alberto Díaz Cáceres
ASAlejandro Serrán‐Jiménez
Alejandro Serrán‐Jiménez
JAJavier Arenas-Montes
Javier Arenas-Montes
PPPABLO PEREZ-MARTINEZ
PABLO PEREZ-MARTINEZ
Background: Food insecurity is linked to poorer cardiovascular health (CVH) outcomes, particularly in underresourced communities, where social determinants of health play a critical role. Despite the recognized connections, there remains a lack of empirical evidence delineating the implications of food insecurity on CVH. CVH, a broader concept than cardiovascular disease, encompasses the overall well‐being of the cardiovascular system and is supported by favorable lifestyle choices and physiological metrics. Particularly in underresourced communities, the study of CVH could provide valuable insights for early intervention and targeted public health initiatives. This study aimed to fill this knowledge gap. Methods and Results: We conducted a cross‐sectional analysis of baseline data from the E‐DUCASS (Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Food Insecurity) program (NCT05379842), a 24‐month randomized study targeting participants at risk for food insecurity. CVH was assessed using the Life's Essential 8 score. The sample included 451 participants aged 12 to 80 years, stratified by age (30.6% children [aged 12–19 years], 35.9% young adults [aged 20–39 years], and 33.5% adults [aged 40–80 years]) and sex (42.1% men and 57.9% women). The mean CVH score was 65.1 (95% CI, 63.9–66.4), with diet, physical activity, nicotine exposure, and body mass index being the lowest‐scoring metrics. Food insecurity significantly influenced CVH; those participants with severe food insecurity had lower CVH scores than those without (effect size, −2.83 [95% CI, −5.10 to −0.56]; P <0.05). Conclusions: Our findings highlight the negative association between food insecurity and CVH in underresourced Mediterranean communities. These results underscore the need for strategies aimed at reducing cardiovascular risk, potentially through health literacy programs like E‐DUCASS, that focus on improving lifestyle and alleviating food insecurity. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT05379842.

19 February 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
PMPablo Caballero María
Pablo Caballero María
JCJavier Caballero-Villarraso
Javier Caballero-Villarraso
JAJavier Arenas-Montes
Javier Arenas-Montes
ACAlberto Díaz Cáceres
Alberto Díaz Cáceres
SNSofía Castañeda Nieto
Sofía Castañeda Nieto
ACAntonio Camargo
Antonio Camargo
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Gut microbiota plays a key role in metabolic homeostasis and the development of T2DM and its complications. With the advance of artificial intelligence (AI), it is possible to develop novel models based on machine learning (ML) that can predict the risk of developing certain diseases and facilitate their early diagnosis, or even take preventive measures in advance. This can be the case of T2DM, for example. Our objective was to develop a predictive model of the risk of developing T2DM based on clinical, biochemical, and intestinal microbiota parameters, which estimates the time margin for developing this disease. To this end, a Deep Learning Multilayer Perceptron (MLP) algorithm was developed and trained with data from real patients from a current large population epidemiological study. The data were normalised and augmented to increase their diversity and avoid overfitting. The neural network developed was optimised, and the best hyperparameters were chosen for model building by Bayesian optimisation. We succeeded in getting the model to return a numerical result corresponding to the number of months it will take for a particular individual to develop T2DM with an accuracy of 95.2%.

16 March 2022 in Spanish Journal of Medicine
Verified
Journal Article
Open access
JRJuan Luis Romero-Cabrera
Juan Luis Romero-Cabrera
IDIsabel De-Castro-Burón
Isabel De-Castro-Burón
EYElena Yubero-Serrano
Elena Yubero-Serrano
ACAlberto Díaz Cáceres
Alberto Díaz Cáceres
ASAlejandro Serrán-Jiménez
Alejandro Serrán-Jiménez
PPPABLO PEREZ-MARTINEZ
PABLO PEREZ-MARTINEZ

9 August 2022 in Revista Española de Casos Clínicos en Medicina Interna
Verified
Journal Article
Open access
JAJavier Arenas-Montes
Javier Arenas-Montes
FMFernando Mora-Martín
Fernando Mora-Martín
SASalvador Aguilar-Alba
Salvador Aguilar-Alba
RSRafael Sánchez-Sánchez
Rafael Sánchez-Sánchez
RPRafael Ángel Fernández de la Puebla
Rafael Ángel Fernández de la Puebla
La pustulosis exantemática generalizada aguda (PEGA) es un tipo de lesión cutánea poco común caracterizada por la aparición rápida e insidiosa de numerosas pústulas estériles sobre un fondo eritematoso. Esta reacción normalmente es desencadenada por fármacos, principalmente antibióticos y más raramente por otros tipos de desencadenantes como infecciones o vacunas. Se presenta el caso de una paciente que desarrolló PEGA tras la administración de la vacuna de Pfizer-BioNTech frente al SARS-CoV-2. Según nuestro conocimiento solo hay seis casos descritos por la vacuna frente al SARS-CoV-2 y ninguno de ellos por la vacuna de Pfizer-BioNTech.

26 August 2024 in Revista Española de Casos Clínicos en Medicina Interna
Verified
Journal Article
Open access
PDF file
SASalvador Aguilar-Alba
Salvador Aguilar-Alba
JAJavier Arenas-Montes
Javier Arenas-Montes
SSSilvia Soriano-Gandullo
Silvia Soriano-Gandullo
ATAntonio Trujillo-Aguilera
Antonio Trujillo-Aguilera
BRBegoña Cortés Rodríguez
Begoña Cortés Rodríguez
El síndrome VEXAS (vacuoles, E1 enzyme, X-linked, autoinflamatory, somatic), descrito por primera vez en 2020, es una enfermedad autoinflamatoria monogénica causada por mutaciones somáticas en el gen UBA1, localizado en el cromosoma X y, por tanto, predominantemente expresada en varones. La edad a la que aparece este síndrome suele ser superior a los 60 años, a diferencia de otras enfermedades autoinflamatorias, y clínicamente se caracteriza por episodios de fiebre periódica, condritis (nasal y/o del pabellón auricular), infiltrados pulmonares y vasculitis. Se presenta el caso de un varón de 76 años con episodios infecciosos/inflamatorios de repetición, diagnosticado mediante la secuenciación de una mutación del gen UBA1. Se instauró tratamiento corticoideo, requiriendo introducción de terapia biológica con ruxolitinib ante la respuesta incompleta.